Simon Erickson (@7Innovator)

Novo Nordisk $NVO just lowered its full year guidance as it acknowledges the increasing competitive threats. The market responds by selling off the stock by 20% today. Is that a valid selloff? Will Novo eventually recover? Here's my take on the NOVO situation:...